BlackRock Health Sciences Trust (BME)
NYSE: BME · Real-Time Price · USD
44.60
+0.11 (0.25%)
Sep 21, 2026, 2:44 PM EDT - Market open
BME Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0 | 0 | 0.01 | 0 | 0 | 0 |
Cash & Short-Term Investments | 0 | 0 | 0.01 | 0 | 0 | 0 |
Cash Growth | -99.08% | -90.94% | 1032.58% | -82.87% | 224.79% | -99.55% |
Receivables | 2.58 | 0.43 | 0.4 | 1.58 | 2.37 | 3.18 |
Prepaid Expenses | - | - | - | 0.01 | - | - |
Other Current Assets | - | - | - | 0.04 | - | - |
Total Current Assets | 2.58 | 0.43 | 0.41 | 1.62 | 2.37 | 3.18 |
Long-Term Investments | 572.02 | 565.64 | 546 | 589.53 | 598.65 | 636.88 |
Long-Term Deferred Charges | 0.02 | 0.02 | 0.08 | 0.08 | 0.08 | 0.09 |
Other Long-Term Assets | - | 4.05 | 3.88 | 4.87 | 5.03 | 8.66 |
Total Assets | 574.62 | 570.14 | 550.38 | 596.1 | 606.13 | 648.81 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.61 | - | 0.49 | - | 0.23 | 12.48 |
Accrued Expenses | 0.64 | 0.73 | 0.65 | 0.63 | 0.7 | 0.71 |
Short-Term Debt | 0.69 | 0.89 | 0.28 | 0.06 | 0.68 | 0.21 |
Current Income Taxes Payable | - | - | - | - | - | 0.01 |
Other Current Liabilities | 0.22 | 0.21 | 2.82 | 7.27 | 4.32 | 9.62 |
Total Current Liabilities | 3.17 | 1.83 | 4.24 | 7.97 | 5.93 | 23.04 |
Total Liabilities | 3.17 | 1.83 | 4.24 | 7.97 | 5.93 | 23.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 357.61 | 357.61 | 381.13 | 417.62 | 424.3 | 390.51 |
Retained Earnings | 213.84 | 210.69 | 165 | 170.52 | 175.9 | 235.27 |
Shareholders' Equity | 571.46 | 568.3 | 546.14 | 588.14 | 600.2 | 625.77 |
Total Liabilities & Equity | 574.62 | 570.14 | 550.38 | 596.1 | 606.13 | 648.81 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.69 | 0.89 | 0.28 | 0.06 | 0.68 | 0.21 |
Net Cash (Debt) | -0.69 | -0.89 | -0.27 | -0.06 | -0.68 | -0.21 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.05 | -0.07 | -0.02 | -0.00 | -0.05 | -0.02 |
Filing Date Shares Outstanding | 12.92 | 12.92 | 13.26 | 13.94 | 13.86 | 13.05 |
Total Common Shares Outstanding | 12.92 | 12.92 | 13.26 | 13.94 | 13.86 | 13.05 |
Working Capital | -0.59 | -1.4 | -3.83 | -6.35 | -3.56 | -19.86 |
Book Value Per Share | 44.22 | 43.97 | 41.20 | 42.18 | 43.30 | 47.96 |
Tangible Book Value | 571.46 | 568.3 | 546.14 | 588.14 | 600.2 | 625.77 |
Tangible Book Value Per Share | 44.22 | 43.97 | 41.20 | 42.18 | 43.30 | 47.96 |